Know Cancer

or
forgot password


Phase 4
N/A
N/A
Not Enrolling
Both
Hepatitis B, Liver Neoplasms, Liver Diseases

Thank you

Trial Information


Inclusion Criteria:



all infants born in Qidong between September 1983 and November 1990

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Principal Investigator

Zongtang Sun, MD

Investigator Role:

Study Director

Investigator Affiliation:

Cancer Institute, Chinese Academy of Medical Sciences

Authority:

China: Ministry of Health

Study ID:

Qidong-HBV-Study

NCT ID:

NCT00222664

Start Date:

September 1983

Completion Date:

December 2004

Related Keywords:

  • Hepatitis B
  • Liver Neoplasms
  • Liver Diseases
  • hepatitis B
  • hepatocellular carcinoma
  • prevention
  • vaccination
  • Neoplasms
  • Hepatitis
  • Hepatitis A
  • Hepatitis B
  • Liver Diseases
  • Liver Neoplasms

Name

Location